This site is intended for Healthcare Professionals only.

Levomepromazine 25mg/1ml solution for injection faces supply disruption

Date:

Share post:

Levomepromazine 25mg/1ml solution for injection will remain unavailable until the week commencing March 7,2022, Department of Health and Social Care (DHSC) said in an update.

While alternative medicines for use in palliative care remain available in ample supply to support an uplift in demand, the date supply resumption of Levomepromazine is yet to be confirmed.

The DHSC has sent a copy of this medicine supply notification to all pharmacy NHS email addresses.

It further informed primary care providers that prescription validation has been temporarily implemented at wholesaler level.

To ensure continuity of supply to patients, the department has advised community pharmacists to work with their local hospitals and request mutual aid if wholesaler supplies are exhausted.

In case pharmacists are not able to secure supplies via mutual aid, they should work with specialist palliative care teams to use alternative medication, the DHSC stated.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

33 % rise in women seeking perinatal mental health support since 2022

One in five new and expectant mothers may be affected by perinatal mental health conditions In a significant uptick...

UK GDP Association Delivers Affordable GDP Consultancy for Small Businesses

“We want to help plug the gap where current consultancies fail these smaller businesses, and ultimately benefit UK...

Pharmacy First vital to amplify NHS digital prescription rollout, WHO report reveals

75 per cent of adults in England are registered for digital prescriptions on the NHS App In a groundbreaking...

Haleon to close Maidenhead manufacturing site affecting 435 jobs

Despite the closure, Haleon will retain its presence in the UK with corporate offices in Weybridge and London Haleon,...